Limaprost alfadex - Ono Pharmaceutical/Sumitomo Dainippon Pharma

Drug Profile

Limaprost alfadex - Ono Pharmaceutical/Sumitomo Dainippon Pharma

Alternative Names: Limaprost; Limaprost alphadex; ONO-1206; OP-1206; Opalmon; Opast; Prorenal

Latest Information Update: 04 Jul 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dainippon Sumitomo Pharma; Ono Pharmaceutical
  • Developer Dainippon Sumitomo Pharma; Meiji Seika Pharma; Ono Pharmaceutical; Sumitomo Dainippon Pharma; Yungjin Pharm Co
  • Class Peripheral vasodilators; Prostaglandins; Small molecules; Unsaturated fatty acids; Vascular disorder therapies
  • Mechanism of Action Platelet aggregation inhibitors; Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Intermittent claudication; Thromboangiitis obliterans
  • Discontinued Carpal tunnel syndrome; Spondylosis

Most Recent Events

  • 29 Jun 2018 Preregisteration for Intermittent claudication in Thailand (PO) prior to June 2018
  • 29 Jun 2018 Preregistration for Thromboangiitis obliterans in Thailand (PO) prior to June 2018
  • 29 Jun 2018 Registered for Intermittent claudication in Thailand (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top